HER2 Expressing or Mutated Advanced Malignant Solid Tumors
1 clinical trials · Condition
◉ Watch HER2 Expressing or Mutated Advanced Malignant Solid Tumors
| Record | Firm | Date |
|---|---|---|
| A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors (NCT06154343) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2022-11-23 |
Track HER2 Expressing or Mutated Advanced Malignant Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.